Dydrogesterone 30 mg
M13-625
Phase 3 small_molecule completed
Quick answer
Dydrogesterone 30 mg for Female Infertility is a Phase 3 program (small_molecule) at Abbott Australasia Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Abbott Australasia Pty Ltd
- Indication
- Female Infertility
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed